Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 6100-6199

6100. U. Schroeder, P. Sommerfeld, B.A. Sabel, “Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier,” Peptides 19(1998):777-780.

6101. U. Schroeder, P. Sommerfeld, S. Ulrich, B.A. Sabel, “Nanoparticle technology for delivery of drugs across the blood-brain barrier,” J. Pharm. Sci. 87(November 1998):1305-1307.

6102. A.E. Gulyaev, S.E. Gelperina, I.N. Skidan, A.S. Antropov, G.Y. Kivman, J. Kreuter, “Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles,” Pharm. Res. 16(October 1999):1564-1569.

6103. A. Friese, E. Seiller, G. Quack, B. Lorenz, J. Kreuter, “Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system,” Eur. J. Pharm. Biopharm. 49(March 2000):103-109.

6104. R.N. Alyautdin, V.E. Petrov, K. Langer, A. Berthold, D.A. Kharkevich, J. Kreuter, “Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles,” Pharm. Res. 14(March 1997):325-328.

6105. R.N. Alyautdin, E.B. Tezikov, P. Ramge, D.A. Kharkevich, D.J. Begley, J. Kreuter, “Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study,” J. Microencapsul. 15(January-February 1998):67-74.

6106. S. Yang, J. Zhu, Y. Lu, B. Liang, C. Yang, “Body distribution of camptothecin solid lipid nanoparticles after oral administration,” Pharm. Res. 16(May 1999):751-757.

6107. J.X. Wang, X. Sun, Z.R. Zhang, “Enhanced brain targeting by synthesis of 3’,5’-dioctanoyl-5-fluoro-2’-deoxyuridine and incorporation into solid lipid nanoparticles,” Eur. J. Pharm. Biopharm. 54(November 2002):285-290.

6108. A. Bargoni, R. Cavalli, G.P. Zara, A. Fundaro, O. Caputo, M.R. Gasco, “Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution,” Pharmacol. Res. 43(May 2001):497-502.

6109. G.P. Zara, A. Bargoni, R. Cavalli, A. Fundaro, D. Vighetto, M.R. Gasco, “Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats,” J. Pharm. Sci. 91(May 2002):1324-1333.

6110. C. Olbrich, A. Gessner, O. Kayser, R.H. Muller, “Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate,” J. Drug Target. 10(August 2002):387-396.

6111. P. Calvo, B. Gouritin, H. Chacun, D. Desmaele, J. D’Angelo, J.P. Noel, D. Georgin, E. Fattal, J.P. Andreux, P. Couvreur, “Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery,” Pharm. Res. 18(August 2001):1157-1166.

6112. L. Fenart, A. Casanova, B. Dehouck, C. Duhem, S. Slupek, R. Cecchelli, D. Betbeder, “Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier,” J. Pharmacol. Exp. Ther. 291(December 1999):1017-1022;

6113. S.I. Rapoport, “Osmotic opening of the blood-brain barrier,” Ann. Neurol. 24(November 1988):677-684.

6114. M.W. Brightman, M. Hori, S.I. Rapoport, T.S. Reese, E. Westergaard, “Osmotic opening of tight junctions in cerebral endothelium,” J. Comp. Neurol. 152(1973):317-326.

6115. S.I. Rapoport, P.J. Robinson, “Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier,” Ann. N.Y. Acad. Sci. 481(1986):250-267.

6116. V. Rousseau, B. Denizot, D. Pouliquen, P. Jallet, J.J. Le Jeune, “Investigation of blood-brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in rats,” MAGMA 5(September 1997):213-222.

6117. Leslie L. Muldoon, Michael A. Pagel, Robert A. Kroll, Simon Roman-Goldstein, Russell S. Jones, Edward A. Neuwelt, “A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery,” AJNR Am. J. Neuroradiol. 20(February 1999):217-222;

6118. L.L. Muldoon, G. Nilaver, R.A. Kroll, M.A. Pagel, X.O. Breakefield, E.A. Chiocca, B.L. Davidson, R. Weissleder, E.A. Neuwelt, “Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain,” Am. J. Pathol. 147(1995):1840-1851.

6119. S.E. Doran, X.D. Ren, A.L. Betz, M.A. Pagel, E.A. Neuwelt, B.J. Roessler, B.L. Davidson, “Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption,” Neurosurgery 36(May 1995):965-970.

6120. G. Nilaver, L.L. Muldoon, R.A. Kroll, M.A. Pagel, X.O. Breakefield, B.L. Davidson, E.A. Neuwelt, “Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption,” Proc. Natl. Acad. Sci. (USA) 92(1995):9829-9833;

6121. E.A. Neuwelt, M.A. Pagel, R.D. Dix, “Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier,” J. Neurosurg. 74(March 1991):475-479.

6122. T. Shen, R. Weissleder, M. Papisov, A. Bogdanov Jr., T.J. Brady, “Monocrystalline iron oxide nanocompounds (MION): physicochemical properties,” Magn. Reson. Med. 29(May 1993):599-604.

6123. Millipore Corp., Viresolve Virus Clearance Selection Guide, 2003;

6124. T. Inamura, T. Nomura, R.T. Bartus, K.L. Black, “Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors,” J. Neurosurg. 81(November 1994):752-758.

6125. R.A. Kroll, M.A. Pagel, L.L. Muldoon, S. Roman-Goldstein, S.A. Fiamengo, E.A. Neuwelt, “Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers,” Neurosurgery 43(October 1998):879-886, 886-889 (discussion). Comment in: B.V. Zlokovic, M.L. Apuzzo, “Strategies to circumvent vascular barriers of the central nervous system,” Neurosurgery 43(October 1998):877-878.

6126. M. Merodio, J.M. Irache, F. Eclancher, M. Mirshahi, H. Villarroya, “Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis,” J. Drug Target. 8(2000):289-303.

6127. P. Calvo, B. Gouritin, H. Villarroya, F. Eclancher, C. Giannavola, C. Klein, J.P. Andreux, P. Couvreur, “Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat,” Eur. J. Neurosci. 15(April 2002):1317-1326.

6128. Y. Persidsky, M. Stins, D. Way, M.H. Witte, M. Weinand, K.S. Kim, P. Bock, H.E. Gendelman, M. Fiala, “A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis,” J. Immunol. 158(1 April 1997):3499-3510.

6129. V.J. Quagliarello, A. Ma, H. Stukenbrok, G.E. Palade, “Ultrastructural localization of albumin transport across the cerebral microvasculature during experimental meningitis in the rat,” J. Exp. Med. 174(1 September 1991):657-672.

6130. H. Wolburg, A. Lippoldt, “Tight junctions of the blood-brain barrier: development, composition and regulation,” Vascul. Pharmacol. 38(June 2002):323-337.

6131. J. Greenwood, S. Etienne-Manneville, P. Adamson, P.O. Couraud, “Lymphocyte migration into the central nervous system: implication of ICAM-1 signaling at the blood-brain barrier,” Vascul. Pharmacol. 38(June 2002):315-322.

6132. M.A. Bogoyevitch, T.S. Kendrick, D.C. Ng, R.K. Barr, “Taking the cell by stealth or storm? Protein transduction domains (PTDs) as versatile vectors for delivery,” DNA Cell Biol. 21(December 2002):879-894.

6133. P.A. Stewart, M. Magliocco, K. Hayakawa, C.L. Farrell, R.F. Del Maestro, J. Girvin, J.C. Kaufmann, H.V. Vinters, J. Gilbert, “A quantitative analysis of blood-brain barrier ultrastructure in the aging human,” Microvasc. Res. 33(March 1987):270-282.

6134. P.A. Fraser, A.D. Dallas, “Permeability of disrupted cerebral microvessels in the frog,” J. Physiol. 461(February 1993):619-632.

6135. A.W. Vorbrodt, D.H. Dobrogowska, M. Tarnawski, A.S. Lossinsky, “A quantitative immunocytochemical study of the osmotic opening of the blood-brain barrier to endogenous albumin,” J. Neurocytol. 23(December 1994):792-800.

6136. A. Ermisch, H.J. Ruhle, R. Landgraf, J. Hess, “Blood-brain barrier and peptides,” J. Cereb. Blood Flow Metab. 5(September 1985):350-357.

6137. W.G. Mayhan, F.M. Faraci, D.D. Heistad, “Disruption of the blood-brain barrier in cerebrum and brain stem during acute hypertension,” Am. J. Physiol. 251(December 1986):H1171-H1175.

6138. T.L. Kemper, G.J. Blatt, R.J. Killiany, M.B. Moss, “Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys,” Acta Neuropathol. (Berl.) 101(February 2001):145-153.

6139. A.W. Vorbrodt, D.H. Dobrogowska, “Interaction of glycated albumin-gold complexes with mouse brain microvascular endothelium,” Folia Histochem. Cytobiol. 37(1999):3-10.

6140. P.C. Bragt, I.L. Bonta, M.J. Adolfs, “Cannulated teflon chamber implant in the rat: a new model for continuous studies on granulomatous inflammation,” J. Pharmacol. Methods 3(January 1980):51-61.

6141. L. Strukelj, “Research on the carcinomatous and granulomatous pocket. II. Diffusion of tetracycline in the carcinomatous and granulomatous pockets,” Friuli Med. 20(November-December 1965):923-928. In Italian.

6142. A. Wohlman, M. Syed, S. Avakian, “Enhancement of drug activity by chymotrypsin. Penicillin penetration into granulomatous lesions and inflammatory fluids,” Experientia 25(15 September 1969):953-954.

6143. I.Ia. Geitman, G.Ia. Kivman, N.A. Kalinina, I.R. Balyn’, L.V. Butylina, “Pharmacokinetics of penicillins in the body of rats, including penetration into a granuloma, with repeated administration of the antibiotics and chymotrypsin,” Antibiotiki 19(November 1974):1012-1017 (in Russian); I.Ia. Geitman, G.Ia. Kivman, N.A. Kalinina, I.R. Balyn’, “The pharmacokinetics of kanamycin, including granuloma penetration, in rats treated with chymotrypsin,” Antibiotiki 18(November 1973):1016-1020 (in Russian).

6144. Y. Akimoto, H. Nishimura, M. Komiya, K. Kaneko, A. Fujii, T. Tamura, “Ampicillin concentrations in human dental granuloma after a single oral administration of talampicillin,” Antimicrob. Agents Chemother. 32(April 1988):566-567; A. Uda, H. Omata, J. Shibutani, H. Nishimura, M. Komiya, Y. Akimoto, K. Kaneko, A. Fujii, “Josamycin concentrations in human dental granuloma after a single oral administration of josamycin,” Gen. Pharmacol. 20(1989):823-825; Y. Akimoto, K. Kaneko, A. Fujii, H. Yamamoto, “Ampicillin concentrations in human radicular granuloma following a single oral dose of bacampicillin,” J. Oral Maxillofac. Surg. 50(January 1992):11-13; Y. Akimoto, Y. Mochizuki, A. Uda, H. Omata, S. Saito, K. Kaneko, A. Fujii, H. Yamamoto, “Josamycin concentrations in radicular cysts following a single oral administration,” Gen. Pharmacol. 24(January 1993):143-145; Y. Akimoto, Y. Mochizuki, A. Uda, J. Shibutani, H. Nishimura, M. Komiya, K. Kaneko, A. Fujii, H. Yamamoto, “Ampicillin concentrations in radicular cysts following a single oral administration of bacampicillin,” Gen. Pharmacol. 24(July 1993):895-898; Y. Akimoto, Y. Mochizuki, A. Uda, H. Omata, J. Shibutani, H. Nishimura, M. Komiya, K. Kaneko, T. Kawana, A. Fujii, et al, “Concentrations of lomefloxacin in radicular cyst and oral tissues following single or multiple oral administration,” J. Nihon Univ. Sch. Dent. 35(December 1993):267-275; Y. Akimoto, A. Uda, H. Omata, J. Shibutani, H. Nishimura, M. Komiya, T. Kawana, K. Kaneko, A. Fujii, T. Kaneda, et al, “Cephalexin concentrations in radicular granuloma following a single oral administration of 250- or 500-mg cephalexin,” Gen. Pharmacol. 25(December 1994):1563-1566; Y. Akimoto, M. Ikeda, H. Omata, J. Shibutani, A. Fujii, T. Kaneda, H. Yamamoto, T. Takato, “Cefaclor concentration in radicular granuloma after a single oral administration,” Gen. Pharmacol. 31(August 1998):283-285.

6145. S. Yagishita, Y. Itoh, T. Nakano, Y. Ono, N. Amano, “Crystalloid inclusions reminiscent of Hirano bodies in autolyzed peripheral nerve of normal Wistar rats,” Acta Neuropathol (Berl.) 47(August 1979):231-236.

6146. L. Weiss, R. Zeigel, O.S. Jung, I.D. Bross, “Binding of positively charged particles to glutaraldehyde-fixed human erythrocytes,” Exp. Cell Res. 70(1972):57-64.

6147. D.L. Schotland, S. DiMauro, E. Bonilla, A. Scarpa, C.P. Lee, “Neuromuscular disorder associated with a defect in mitochondrial energy supply,” Arch. Neurol. 33(July 1976):475-479.

6148. G.W. Farrants, S. Hovmoller, A.M. Stadhouders, “Two types of mitochondrial crystals in diseased human skeletal muscle fibers,” Muscle Nerve 11(January 1988):45-55.

6149. N.G. Ryley, R. Forman, D. Barlow, K.A. Fleming, J.M. Trowell, “Liver abnormality in ovarian hyperstimulation syndrome,” Hum. Reprod. 5(November 1990):938-943.

6150. E. O’Gorman, T. Piendl, M. Muller, D. Brdiczka, T. Wallimann, “Mitochondrial intermembrane inclusion bodies: the common denominator between human mitochondrial myopathies and creatine depletion, due to impairment of cellular energetics,” Mol. Cell Biochem. 174(September 1997):283-289.

6151. K. Matsumuro, S. Izumo, Y. Minauchi, M. Inose, I. Higuchi, M. Osame, “Chronic demyelinating neuropathy and intra-axonal polyglucosan bodies,” Acta Neuropathol. (Berl.) 86(1993):95-99.

6152. C. Vital, S. Bouillot, M.H. Canron, A. Vital, “Schwannian crystalline-like inclusions bodies (Fardeau-Engel bodies) revisited in peripheral neuropathies,” Ultrastruct. Pathol. 26(January-February 2002):9-13.

6153. J. Pan, C. Leygraf, D. Thierry, A.M. Ektessabi, “Corrosion resistance for biomaterial applications of TiO2 films deposited on titanium and stainless steel by ion-beam-assisted sputtering,” J. Biomed. Mater. Res. 35(5 June 1997):309-318.

6154. A. Nanci, J.D. Wuest, L. Peru, P. Brunet, V. Sharma, S. Zalzal, M.D. McKee, “Chemical modification of titanium surfaces for covalent attachment of biological molecules,” J. Biomed. Mater. Res. 40(May 1998):324-335.

6155. C. Yongli, Z. Xiufang, G. Yandao, Z. Nanming, Z. Tingying, S. Xinqi, “Conformational changes of fibrinogen adsorption onto hydroxyapatite and titanium oxide nanoparticles,” J. Colloid Interface Sci. 214(1 June 1999):38-45.

6156. S.Y. Kwak, S.H. Kim, S.S. Kim, “Hybrid organic/inorganic reverse osmosis (RO) membrane for bactericidal anti-fouling. 1. Preparation and characterization of TiO2 nanoparticle self-assembled aromatic polyamide thin-film-composite (TFC) membrane,” Environ. Sci. Technol. 35(1 June 2001):2388-2394.

6157. P.A. Ramires, A. Romito, F. Cosentino, E. Milella, “The influence of titania/hydroxyapatite composite coatings on in vitro osteoblast behaviour,” Biomaterials 22(June 2001):1467-1474.

6158. F.Y. Oliva, L.B. Avalle, V.A. Macagno, C.P. De Pauli, “Study of human serum albumin-TiO(2) nanocrystalline electrodes interaction by impedance electrochemical spectroscopy,” Biophys. Chem. 91(2 July 2001):141-155.

6159. T. Sawase, A. Wennerberg, K. Baba, Y. Tsuboi, L. Sennerby, C.B. Johansson, T. Albrektsson, “Application of oxygen ion implantation to titanium surfaces: effects on surface characteristics, corrosion resistance, and bone response,” Clin. Implant Dent. Relat. Res. 3(2001):221-229.

6160. M. Manso, S. Ogueta, P. Garcia, J. Perez-Rigueiro, C. Jimenez, J.M. Martinez-Duart, M. Langlet, “Mechanical and in vitro testing of aerosol-gel deposited titania coatings for biocompatible applications,” Biomaterials 23(January 2002):349-356.

6161. D.E. MacDonald, N. Deo, B. Markovic, M. Stranick, P. Somasundaran, “Adsorption and dissolution behavior of human plasma fibronectin on thermally and chemically modified titanium dioxide particles,” Biomaterials 23(February 2002):1269-1279.

6162. K.R. Meier, M. Gratzel, “Redox targeting of oligonucleotides anchored to nanocrystalline TiO2 films for DNA detection,” Chemphyschem 3(15 April 2002):371-374.

6163. J. Pan, G. Benko, Y. Xu, T. Pascher, L. Sun, V. Sundstrom, T. Polivka, “Photoinduced electron transfer between a carotenoid and TiO2 nanoparticle,” J. Am. Chem. Soc. 124(20 November 2002):13949-13957.

6164. T. Paunesku, T. Rajh, G. Wiederrecht, J. Maser, S. Vogt, N. Stojicevic, M. Protic, B. Lai, J. Oryhon, M. Thurnauer, G. Woloschak, “Biology of TiO(2)-oligonucleotide nanocomposites,” Nat. Mater. 2(May 2003):343-346.

6165. H. Kong, J.L. Wilkinson, J.Y. Coe, X. Gu, M. Urness, T.H. Kim, J.L. Bass, “Corrosive behaviour of Amplatzer devices in experimental and biological environments,” Cardiol. Young 12(May 2002):260-265.

6166. M. Hannuksela, J. Hassi, “Hairdresser’s hand,” Derm. Beruf. Umwelt 28(1980):149-151.

6167. D.J. Hogan, “Subungual trichogranuloma in a hairdresser,” Cutis 42(August 1988):105-106.

6168. M.R. Patel, L. Bassini, R. Nashad, M.T. Anselmo, “Barber’s interdigital pilonidal sinus of the hand: a foreign body hair granuloma,” J. Hand Surg. 15(July 1990):652-655.

6169. S. Kremmer, J.M. Rohrbach, A. Frohn, A. Eckstein, H.J. Thiel, “Tarantule hairs as corneal foreign bodies,” Klin. Monatsbl. Augenheilkd. 206(April 1995):277-278. In German.

6170. Joseph Mendel Yoffey, Frederick Colin Courtice, Lymphatics, Lymph and the Lymphomyeloid Complex, Academic Press, New York, 1970.

6171. Bjorn E.W. Nordenstrom, “An additional circulatory system: Vascular-Interstitial Closed Electric Circuits (VICC),” J. Biol. Phys. 15(1987):43-55.

6172. Steven M. Block, Charles L. Asbury, Joshua W. Shaevitz, M.J. Lang, “Probing the kinesin reaction cycle with a 2D optical force clamp,” Proc. Natl. Acad. Sci. (USA) 100(4 March 2003):2351-2356.

6173. A. Rolland, N. Wagner, A. Chatelus, B. Shroot, H. Schaefer, “Site-specific drug delivery to pilosebaceous structures using polymeric microspheres,” Pharm. Res. 10(December 1993):1738-1744.

6174. Sally S. Tinkle, James M. Antonini, Brenda A. Rich, Jenny R. Roberts, Rebecca Salmen, Karyn DePree, Eric J. Adkins, “Skin as a route of exposure and sensitization in chronic beryllium disease,” Environ. Health Perspect. doi:10.1289/ehp.5999 (available at, online 24 February 2003; (abstract)

6175. J. Lademann, N. Otberg, H. Richter, H.J. Weigmann, U. Lindemann, H. Schaefer, W. Sterry, “Investigation of follicular penetration of topically applied substances,” Skin. Pharmacol. Appl. Skin Physiol. 14(2001):17-22; J. Lademann, H.J. Weigmann, C. Rickmeyer, H. Barthelmes, H. Schaefer, G. Mueller, W. Sterry, “Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice,” Skin. Pharmacol. Appl. Skin Physiol. 12(September-October 1999):247-256.

6176. H. Yildirim Erbil, A. Levent Demirel, Yonca Avci, Olcay Mert, “Transformation of a simple plastic into a superhydrophobic surface,” Science 299(28 February 2003):1377-1380.

6177. W.G. Kreyling, M. Semmler, F. Erbe, P. Mayer, S. Takenaka, H. Schultz, G. Oberdorster, A. Ziesenis, “Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low,” J. Toxicol. Environ. Health A 65(25 October 2002):1513-1530.

6178. G. Oberdorster, Z. Sharp, V. Atudorei, A. Elder, R. Gelein, A. Lunts, W. Kreyling, C. Cox, “Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats,” J. Toxicol. Environ. Health A 65(25 October 2002):1531-1543.

6179. J.D. Eakins, A.E. Lally, “The transfer to land of actinide bearing sediments from the Irish Sea by spray,” Sci. Total Environ. 35(1984):23-32.

6180. B. Yurke, A.J. Turberfield, A.P. Mills, Jr., F.C. Simmel, J.L. Neumann, “A DNA-fuelled molecular machine made of DNA,” Nature 406(10 August 2000):605-608;

6181. Friedrich C. Simmel, Bernard Yurke, “Using DNA to construct and power a nanoactuator,” Phys. Rev. E 63(April 2001):041913.

6182. Friedrich C. Simmel, Bernard Yurke, “A DNA-based molecular device switchable between three distinct mechanical states,” Appl. Phys. Lett. 80(4 February 2002):883-885;

6183. Commission on Life Sciences (CLS), Toxicity of Military Smokes and Obscurants, Vol. 2, National Academies Press, 1999, pp. 68-96.

6184. Rosemary Dunford, Angela Salinaro, Lezhen Cai, Nick Serpone, Satoshi Horikoshi, Hisao Hidaka, John Knowland, “Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients,” FEBS Lett. 418(24 November 1997):87-90.

6185. N. Serpone, A. Salinaro, A.V. Emeline, S. Horikoshi, H. Hidaka, J. Zhao, “An in vitro systematic spectroscopic examination of the photostabilities of a random set of commercial sunscreen lotions and their chemical UVB/UVA active agents,” Photochem. Photobiol. Sci. 1(December 2002):970-981.

6186. W.G. Wamer, J.J. Yin, R.R.Wei, “Oxidative damage to nucleic acids photosensitized by titanium dioxide,” Free Radic. Biol. Med. 23(1997):851-858.

6187. M. Rouabhia, D.L. Mitchell, M. Rhainds, J. Claveau, R. Drouin, “A physical sunscreen protects engineered human skin against artificial solar ultraviolet radiation-induced tissue and DNA damage,” Photochem. Photobiol. Sci. 1(July 2002):471-477.

6188. C. Vyvyan Howard, “Nano-particles and Toxicity,” 2 April 2003;

6189. M. Gumbleton, “Caveolae as potential macromolecule trafficking compartments within alveolar epithelium,” Adv. Drug Delivery Rev. 49(28 July 2001):281-300.

6190. K. Donaldson, V. Stone, P.S. Gilmour, D.M. Brown, W. MacNee, “Ultrafine particles: mechanisms of lung injury,” Phil. Trans. Roy. Soc. Lond. 358(2000):2741-2749.

6191. J. Donaldson, V. Stone, W. MacNee, “The toxicology of ultrafine particles,” in C.V. Howard, R.L. Maynard, eds., Particulate Matter: Properties and Effects Upon Health, BIOS Scientific Publishers Ltd. (Oxford), Springer (New York), 1999, pp. 115-129.

6192. G. Oberdorster, “Toxicology of ultrafine particles: in vivo studies,” Phil. Trans. R. Soc. Lond. 358(2000):2719-2740.

6193. J. Donaldson, V. Stone, A. Clouter, L. Renwick, W. MacNee, “Ultrafine particles,” Occup. Environ. Med. 58(March 2001):211-216.

6194. K. Donaldson, D. Brown, A. Clouter, R. Duffin, W. MacNee, L. Renwick, L. Tran, V. Stone, “The pulmonary toxicology of ultrafine particles,” J. Aerosol Med. 15(Summer 2002):213-220.

6195. C.A. Dick, D.M. Brown, K. Donaldson, V. Stone, “The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types,” Inhal. Toxicol. 15(January 2003):39-52.

6196. A.L. Lambert, J.B. Mangum, M.P. DeLorme, J.L. Everitt, “Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression,” Toxicol. Sci. 72(April 2003):339-346.

6197. A. Seaton, W. MacNee, K. Donaldson, D. Godden, “Particulate air pollution and acute health effects,” Lancet 345(21 January 1995):176-178.

6198. A. Nemmar, M.F. Hoylaerts, P.H. Hoet, J. Vermylen, B. Nemery, “Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis,” Toxicol. Appl. Pharmacol. 186(1 January 2003):38-45.

6199. N. Li, C. Sioutas, A. Cho, D. Schmitz, C. Misra, J. Sempf, M. Wang, T. Oberley, J. Froines, A. Nel, “Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage,” Environ. Health Perspect. 111(April 2003):455-460.


Last updated on 16 April 2004